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Abstract 
Natural experiments are an important methodology often used to answer research questions that 
would, otherwise, be impossible to address, or employed because of ethical concerns about the use 
of randomisation to interventions that carry known risks. The UK Medical Research Council (MRC) 
recently produced an extremely useful document discussing the nature and significance of natural 
experiments within medical and public health research. In this paper, however, we suggest that the 
MRC document's definition of the term ‘natural experiment’ is insufficiently precise. In response, we 
offer a taxonomy of different types of natural experiments and related methods, and explore the 
ethical implications of these different types. We argue that while the ethical issues that may arise 
within natural experiments in relation to risks of harm or informed consent may differ from those 
within the randomised controlled trial, they are not thereby less pressing. The implications of the 
argument are explored and recommendations made for those involved in research governance. 
 
Introduction 
It might be assumed that natural experiments do not raise any ethical issues. Prominent 
international1–5 and national6–8 research ethics guidelines and regulations do not explicitly refer to 
natural experiments. The literature on the design and use of natural experiments, even major texts, 
9,10 appears also to be silent on these issues. It is, therefore, hardly a surprise that the recent 
guidance from the UK Medical Research Council (MRC) on natural experiments11 says so little about 
ethics. Where ethics is mentioned, it is principally by way of suggesting that the choice to conduct a 
natural experiment obviates certain ethical issues. Thus, discussing the use of the natural 
experiment in preference to the randomised controlled trial (RCT), the report states: "It may be 
unethical to manipulate exposure in order to study effects on health if the intervention has other 
known benefits, if it has been shown to work in other settings, or if its main purpose is to achieve 
non-health outcomes (p.7).11" 
The MRC document implies, through the absence of discussion, that natural experiments themselves 
do not raise any problematic ethical issues. By contrast, in this paper, we argue that at least some 
natural experiments can create significant ethical issues. First, we begin by suggesting that the MRC 
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are too quick to treat all kinds of natural experiments as if they were a unified group. We offer 
instead a twofold classification of natural experiments based on a number of methodological 
features. Second, based on these distinctions, we can see that at least some natural experiments 
generate important ethical issues that need to be explored. While we agree with the MRC report 
that there may well be ethical reasons for choosing to use a natural experiment rather than an RCT, 
the distinction itself does not eliminate the need to consider relevant ethical issues. Here, we only 
have space to discuss two of the most significant: issues relating to harms and benefits and 
considerations relating to informed consent. 
 
A typology of natural experiments 
There are many different definitions of the natural experiment available (see appendix 1 of the MRC 
document11). The MRC document itself defines natural experiments as: "events, interventions or 
policies which are not under the control of researchers, but which are amenable to research which 
uses the variation in exposure that they generate to analyse their impact (p.4).11" 
It further states that in a natural experiment ‘the intervention is not undertaken for the purposes of 
research’ and that ‘variation in exposure and outcomes is analysed using methods that attempt to 
make causal inferences’ (p.4). However, while this definition captures many key features of the 
natural experiment and distinguishes this design from the ‘true’ experiment where variables are fully 
under the control of the researcher—as exemplified by the RCT—it provides an insufficiently precise 
definition of natural experiments. For example, it does not distinguish this design and the quasi-
experiment,12 and nor does it discriminate between different kinds of natural experiments 
distinguished according to the different aspects of a study that may be subject to control by the 
researcher. In order to explore the ethical issues to which natural experiments give rise, one should 
first establish, and differentiate, the structural features of these different designs. 
To consider first the quasi-experiment, this can be thought of as a deliberate, manipulable 
intervention designed to provide the conditions to observe differences between groups, where 
assignment to those groups was not random.12 For example, Haukoos et al13 evaluated the use of 
opt-out and opt-in HIV screening in the emergency room of a US hospital. The evaluation was 
performed in computerised kiosks, programmed for opt-out consent in the first phase of the study, 
but for opt-in consent in the second phase. In an earlier study, Goetz et al14 evaluated an 
intervention designed to increase the rate of HIV testing by introducing it in two Veterans Health 
Administration facilities while three other facilities served as control sites. In both of these examples, 
the intervention is able to be manipulated—in terms of its nature, timing, duration and whether it 
takes place at all. However, allocation of individuals to the arms of the study is not decided 
randomly, but is predetermined in terms of temporal or geographical patterns of hospital 
attendance. Although inclusion and exclusion criteria may be specified in a similar way to an RCT, the 
researcher has to work with predetermined treatment and control groups. 
Natural experiments, in contrast, concern interventions that are not fully manipulated by the 
researcher—the interventions are ‘natural’ not by way of contrast with ‘human’ interventions, but to 
reflect the fact of their not being deliberately manipulated. In contrast to a quasi-experiment, 
whether the intervention occurs at all is not under the researcher's control in a natural experiment, 
although other aspects of the study may be (see table 1). In some instances—which we term type 1 
(‘no control’) natural experiments—the intervention being tested is wholly outside the researcher's 
control. A researcher wishing to study the impact of an earthquake or an epidemic cannot control 
where it occurs, those whom it affects or when it starts or finishes. Much the same would apply in 
relation to the impact of national legislation such as licensing regulations,15 a ban on smoking16 or 
on the sale of coal,17 or the unexpected non-availability of a vaccine.18 In other cases—which we 
call type 2 (‘partial control’) natural experiments—some control of the intervention on the part of 
the researcher is possible. An example in public health would be a health promotion initiative or a 
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new form of vaccination. Although whether such measures are introduced is not within the 
researcher's control, he or she might be able to arrange with the relevant authorities that the 
programme should be rolled out sequentially in different regions so as to create a control condition, 
or that it should not be initiated until a certain date, so as to obtain comparative baseline data. In 
both types of natural experiments, the imperfect level of experimental control sets certain 
constraints on the measurement of outcome—its timing, frequency and indeed the types of 
outcomes that can be measured. Therefore, while the researcher can make some decisions 
regarding the procedures used to measure outcomes within a natural experiment, this is typically to 
a lesser degree than in an RCT or a quasi-experiment. 
 
Table 1:  
Aspects of a study over which experimental control can be exerted, and the degree of such control 
 
  Intervention 
   
 
That it 
occurs 
Where 
and 
when 
To 
whom 
Its 
nature 
Its 
termination 
Comparator 
condition 
Confounding 
variables 
Measurement 
Type 1 natural 
experiment 
None None None None None None None* Partial 
Type 2 natural 
experiment 
None Partial Partial None None Partial Partial Partial 
Quasi-
experiment 
Full Partial Partial Full Full Full Partial Full 
Randomised 
controlled trial 
Full Full Full Full Full Full Full Full 
*A degree of statistical control may nonetheless be possible, such as through the use of instrumental 
variables.24 
As in the case of the quasi-experiment, the comparison groups in a natural experiment are not 
formed through random allocation, and so the study does not have the protection from 
confoundingi that randomisation confers.19 In all these non-true experiments, causal inferences, 
therefore, rely on the assumption that allocation is ‘plausibly ‘as if’ random’ (p.282).20 Thus, in a 
study of the effect of iron storage on cardiac ischaemia, Germain et al21 compared individuals who 
were regular blood donors with those who had been disqualified from donation on the basis of a 
falsely reactive test for transmissible disease, arguing that such false tests are ‘quasi-random’. Such 
an assumption can always be disputed,ii hence, the power of methods employing true 
randomisation. 
Table 1 summarises the dimensions of control possible in the different types of research design. As 
the degree of control over the conditions of the experiment and over the influence of extraneous 
variables decreases, so too does the potential internal validity of the study—that is, its ability to 
make robust causal inferences.23 In the RCT, subject to some practical constraints, there is 
potentially full control over the conduct of the study, and it, thereby, has the highest degree of 
internal validity. The differences between the three types of non-true experiments, which the MRC 
document does not clearly distinguish, are important. These designs exhibit different 
methodological characteristics and are, therefore, best treated as distinct so that appropriate steps 
can be taken to minimise potential bias. In addition to this methodological reason for accepting a 
more complex typology of natural experiments, there are strong ethical reasons to do so. 
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The ethical issues 
Given the methodological features of the different types of natural experiments outlined in the 
previous section, the ethical issues that arise can now be considered. While a number of such issues 
could be examined, weighing potential harm and benefits and the role of informed consent are 
perhaps most crucial, and our attention will focus on these, drawing comparisons with the RCT. 
 
Weighing the risk of potential harms and benefits in natural experiments 
Risk of harm to participants is a central concern in the ethics of RCTs, and a primary focus in relevant 
international research ethics guidelines. The Declaration of Helsinki, for example, states that 
‘medical research involving human subjects may only be conducted if the importance of the 
objective outweighs the risks and burdens to the research subjects’.1 In considering harms in 
research, one can distinguish between an intrinsic risk of harm (one that is an intrinsic feature of the 
phenomenon being studied, and is, thus, present at the outset of the study) and an adventitious risk 
of harm (one that arises through unintended or unpredictable, or at least unpredicted, 
circumstances once the study is underway). Hence, a side effect of a drug that is being tested would 
be an intrinsic harm, whereas a breach of confidentiality relating to a participant's personal data in 
such a study would be a potential adventitious harm. 
At the core of concerns about intrinsic harms in the RCT is the notion that such a study is an 
‘artificial’ phenomenon, and that any risk of harm that arises within it has, therefore, been created 
by the investigator. Conversely, it might be thought that a natural experiment comes into being 
independently of the investigator, and this might seem to absolve the researcher from responsibility 
for any harm that transpires. However, as noted in table 1, different types of natural experiments 
allow for different degrees of methodological control. The greater the researcher's capacity to 
influence the design features of a study, the greater the opportunity to influence the occurrence and 
magnitude of any potential intrinsic harms, and thereby the greater the responsibility on the 
researcher to act accordingly. 
In a natural experiment, even if researchers are not in a position to control intrinsic harm—and, on 
the principle of ought implies can, would have no obligation to do so—they should ensure that they 
respond to adventitious harm, particularly as they may be best placed to identify such harm through 
the data collection process. Thus, a natural experiment of an infectious disease could exemplify two 
forms of adventitious harm: it might be noted that the behaviour of some members of the 
community is placing them at avoidable risk of infection, or that public health measures are being 
misunderstood or inappropriately applied. It is, also, possible for adventitious harm to derive from 
the research process; the presence of the researcher, or the way in which data are collected, could 
give rise to anxiety, or lead to untoward changes in behaviour—possibly based on a 
misapprehension of the researcher's role—in those observed. Alternatively, the way in which data 
are handled could lead to harm through a failure fully to observe requirements of anonymity or 
confidentiality.25 Accordingly, the investigator may have a duty to respond to potential harm to 
participants within a natural experiment, just as in any other type of study. For example, there might 
be a beneficence-based duty to warn if individuals are placing themselves at risk of infection, or a 
non-maleficence-based duty to take some sort of restorative or compensatory action in the event of 
harm arising from a neglect of confidentiality. This will have implications for the need to monitor for 
potential harms within at least some natural experiments, just as in RCTs.iii 
Given the risk of adventitious harm in at least some natural experiments, the investigator will have 
the same twofold duty as the trialist conducting an RCT: to minimise such harm and to justify any 
such harm as remains.27 The first of these may present a challenge in this context, as a natural 
experiment is by definition not (fully) under the investigator's control, and the ability to intervene so 
as to minimise potential harm is thereby limited (depending on the nature and origin of the harm in 
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question). The investigator may, thus, be in the morally invidious position of perceiving a 
requirement to act in the interests of research participants’ welfare, but having little scope to do so. 
However, as we saw above, in other cases, such as quasi-experiments and type 2 natural 
experiments, certain aspects of the research may be under the researcher's control, creating the 
opportunity for action to minimise potential harm. 
The second requirement—justification of any remaining harm—is also potentially problematic. One 
way in which risk of harm in research is classically justified is in terms of its relationship to the 
potential countervailing benefits of the study,1 ,28 taking due account of the relative extent to 
which benefits accrue to research participants or to society. Here, a proviso is necessary by way of a 
distinction between the potential benefits of whatever is being studied and those accruing from the 
fact of studying it. If the object of study is a public health intervention, just as the investigators are 
not responsible for any intrinsic harm of such an initiative, they similarly cannot claim credit for its 
intrinsic benefit. However, any benefits that may arise from investigating this initiative—for 
example, those arising from its modification in the light of findings from the study and its 
subsequent rolling out on a broader scale––could play a role in justifying any adventitious harm. 
Against this background, the researcher conducting a natural experiment may seem to be at a 
disadvantage. Given the lesser internal validity of this design vis-à-vis the RCT, evidence of potential 
benefit may be far less robust, and thus, carry less weight in a justification for risk of harm. Any claim 
that the potential benefits of the findings from a natural experiment outweigh the potential harms 
must, therefore, be qualified by the uncertainty that will inevitably surround any such benefits. 
However, while the probability of benefit may be unclear, its potential magnitude may be 
considerable. Natural experiments are frequently used to evaluate interventions whose scale and 
geographical dispersion make any sort of planned experiment impractical—but this same feature 
suggests that any benefits arising from the evaluation, and subsequent implementation, of such an 
intervention may be substantial by virtue of their widespread application. The MRC document gives 
as examples of phenomena that might be studied through a natural experiment ‘the effect of famine 
on the subsequent health of children exposed in utero, or the effects of clean air legislation, indoor 
smoking bans, and changes in taxation of alcohol and tobacco’ (p.4).11 The study of each of these 
has the potential for far-reaching benefit, provided that the information gained from the natural 
experiment can be translated into appropriate changes in policy or practice. 
The category of natural experiments used in the MRC document does not, therefore, correspond to 
cases where the researcher has no responsibility for possible harms. Where harms can arise, no less 
explicit a justification is required of these harms than in an RCT, though how potential benefits 
feature in such a justification may be rather different. Both the investigator and any research ethics 
committee evaluating a protocol must weigh any potential risks and benefits extremely carefully. 
Moreover, the extent to which harms can be either prevented or remediated in a natural 
experiment may, in turn, create ethical challenges. For example, just as the MRC suggests that a 
natural experiment might be preferable to an RCT for ethical reasons, a concern about harm that 
could result from an ‘as-if random’ experiment might influence the choice of method. As an 
illustration, the effect on accidents of introducing novel traffic calming measures in urban areas 
could be estimated using a type 1 natural experiment (the researchers are completely independent 
of the policy makers) or a type 2 natural experiment (the researchers arrange with policy makers to 
introduce the changes in a gradual way to more effectively answer the research question). Given 
what we know about the effects of existing traffic calming strategies,29 it might be argued that any 
delay in introducing the new measures solely to enhance the robustness of the research is morally 
problematic. Another example where the methodology may be chosen because of concerns about 
harm would be a rejection of the use of any quasi-experiment or natural experiment in favour of 
another design, such as a case–control study.30 This may be considered preferable as retrospective 
studies are less likely to raise concerns about intrinsic or adventitious harms.iv 
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Informed consent and participation in natural experiments 
Informed consent has a similarly central role in research ethics to that of risk of harm, and similar 
prominence in research ethics guidelines, where it is commonly regarded as a moral prerequisite for 
a study to take place.1 ,5 Only rarely is consent seen as a negotiable requirement.31 Seeking 
informed consent is traditionally held to be a means of respecting an individual's autonomy, and in 
the context of participation in research, it provides a permission or justification for involving that 
individual. For example, Holm and Madsen (p.12)32 suggest that ‘the basic idea of informed consent 
is that a researcher is only (ethically and/or legally) justified in using a research subject in a project if 
the research subject has consented to being so used’. 
Here, consent is seen as a licence for the researcher to do something to research participants; for 
example, to randomise them to two or more alternative treatments. In a natural experiment, in 
contrast to an RCT or a quasi-experiment, the intervention or phenomenon under study is one that 
may take place without the investigator's involvement, and the issue of doing something to 
participants seems not to arise. It may be that the issue of consent is not mentioned in the MRC 
document because it is not seen as necessary for this reason. Again, however, things are, perhaps, 
more complicated than this suggests. In at least some natural experiments, researchers are not 
doing anything to participants, but they may well know that preventable negative outcomes may 
occur if circumstances change during the study. In such cases, researchers would be unwise to rely 
on the idea that such consequences were the result of what they allowed to happen, rather than 
what they did or intended to do.v Leaving to one side the many ethical issues that it raises, an aspect 
of the Tuskegee syphilis study—in which the natural progression of the disease was monitored in a 
sample of African–American men—is instructive as a way to see the importance of the distinction.34 
Once treatment options became available during the study, the researchers’ failure to intervene is a 
case of adventitious harm for which they were responsible; moreover, their responsibility is 
heightened by the fact that participants were not made aware of this new information, and could 
not, therefore, make a decision on continued involvement in the study. 
So, it should not be assumed that there is no role for consent in relation to natural experiments, but 
nor do we suggest that informed consent is always required prior to the involvement of every 
participant, particularly in public health or other community-level research.35 Each proposed study 
should be considered on an individual basis. Often, consent to the receipt of an intervention within 
the context of a natural experiment will not be possible. However, the consent requirement may 
persist in relation to data collection, unless such information is publicly available or aggregated, and 
need not, therefore, be collected from individuals. Thus, Costello et al 36 studied the effect of a 
change in family income on children's mental health via annual psychiatric assessments, for which, 
individual consent would be required, whereas Herttua et al 37 used available mortality register data 
to study the effect of changes in the price of alcohol on mortality, with no requirement for individual 
consent. 
Moreover, even if the ‘consent’ component of informed consent does not come into play as a form 
of authorisation, the need to ‘inform’ may remain, as the latter may be as important as the former 
as a means of protecting an individual's autonomy. If new information arises during the course of a 
natural experiment that has implications for the welfare or autonomy of those being studied, and 
these implications are sufficiently serious, the researcher may be obliged to convey this information 
as part of a duty to warn. This obligation may be heightened where individual participants are 
readily identifiable (suggesting that the information can be passed on promptly and effectively) and 
where some sort of relationship has been established between participant and the researcher, such 
as where information has been previously collected at an individual level. However, the obligation to 
disclose information need not depend on either of these considerations; the simple fact that the 
researcher has come into possession of information that bears on participants’ well-being places an 
a priori onus on the researcher to act in response to this. 
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The fact that consent to an intervention is likely not to be feasible in at least some natural 
experiments (e.g., type 1) gives rise to an ethical problem relating to risk of harm. The role of a 
harm–benefit calculation as a justification of risk of harm has already been explored. An additional 
argument is that potential harms are justified to the extent that they are consented to (and to the 
extent that we can overcome the difficulties of obtaining the necessary levels of comprehension and 
recall on the part of the participant38). Consent here is construed as a necessary condition, even if 
not a sufficient condition, for exposing individuals to risk of harm.vi The impossibility, in most cases, 
of obtaining consent to an intervention that is the subject of a natural experiment removes, 
therefore, its justificatory role in relation to risk of adventitious harm. Thus, the removal of one 
moral requirement heightens another: accepting that consent is not morally required in such 
circumstances also means that the researcher cannot appeal to consent as a moral justification for 
any risk of harm. The researcher may, therefore, have to compensate for the absence of this 
function of consent in some other way. 
It is certainly the case that many interventions suited to evaluation through a natural experiment—
particularly within public health—may be ones for which members of the public would not normally 
expect their individual consent to be sought.39 One possible way to compensate here for the 
absence of consent—and the consequent absence of its justificatory role in respect of harm—would 
be to set a low threshold for the possible harms in question and see an obligation as being placed 
upon the researchers to constantly monitor for such harms. Any research ethics committee would 
be under a corresponding obligation to assure itself that such monitoring was to be undertaken. A 
second option would be to explore other indirect means of determining the acceptability of the 
research to the participants, perhaps through different forms of community consent, community 
engagement or hypothetical ‘consent’. However, there are good reasons to think that such methods 
are a poor substitute for consent, at least in terms of the role of authorisation.39 Investigators 
should certainly not just assume that because their research uses a natural experiment, there are no 
issues relating to consent, and research ethics committees and researchers should consider, prior to 
a study being conducted, how they should address such issues. 
 
Conclusion 
The term ‘natural experiment’ is one that tends to be used imprecisely. The taxonomy offered in this 
paper provides a means of distinguishing different types of natural experiments. Such distinctions 
are not of mere academic interest, as these different types have both methodological and ethical 
implications; some key issues in relation to the latter are summarised in table 2. Certain elements of 
at least some natural experiments can potentially be controlled or influenced by the researchers, so 
it does not follow that they are automatically absolved of ethical responsibility. While the ethical 
issues that may arise in relation to risks of harm or informed consent may differ from those of the 
RCT, they are not thereby less pressing. One general governance issue that arises from this 
discussion is how to deal with the emergence of adventitious risk during a natural experiment. The 
use of an oversight committee performing a similar role to that of a data monitoring committee 
would be one option. Such a recommendation might be seen by some as excessive and bureaucratic, 
but on the other hand, it provides an important safeguard for participants, and this is particularly 
important where individuals do not or cannot consent to participate in such studies. In addition, 
ethical guidelines specific to natural experiments could usefully be developed to help researchers 
and research ethics committees to identify and deliberate about the important ethical issues that 
can arise in the use of this valuable research design. 
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Table 2: Summary of ethical implications of risk of harm and informed consent in relation to type 1 
and type 2 natural experiments 
  Risk of harm Informed consent 
 
Intrinsic harms Adventitious harms 
Consent to an 
intervention 
Consent to data 
collection 
Type 1 
natural 
experiment 
Researcher has no 
control over these 
harms, and thus, no 
duty is placed on the 
researcher to respond 
to them 
The researcher may be 
able to control, and thus 
prevent or limit, 
adventitious harms, and 
will, therefore, have a 
duty to do so, and to 
justify any risk of such 
harm that remains  
Lack of control over the 
intervention removes the 
need to seek consent, but 
a duty to inform may 
persist in relation to risks 
and consequences of 
participation  
Unless the data 
are already in a 
publicly available 
or aggregate 
form, consent to 
their collection is 
prima facie 
required  
Type 2 
natural 
experiment 
Researcher has limited 
control over these 
harms and thus has a 
correspondingly 
limited duty to respond 
The greater the control 
over the intervention, the 
greater the opportunity to 
inform (particularly if 
participants are more 
readily identifiable than in 
a type 1 natural 
experiment)  
 
Footnotes 
i. Confounding refers to the presence of an extraneous variable that has a statistical 
association with both (a) the factor being tested in an experiment (ie, the groups defined by 
the intervention variable) and (b) the outcome of interest, such that the estimate of the 
between-group difference in the outcome is (potentially) biased. These two statistical 
associations involving the extraneous variable are joint necessary conditions for 
confounding; as randomisation obviates (at least asymptotically) an association between the 
extraneous variable and the factor, it thereby obviates confounding. 
ii. While the assumption is always contestable, its plausibility depends on the circumstances of 
the study. In some instances, these may strongly favour the ‘as if random’ presupposition. 
Thus, Dunning20 cites a study by Doherty et al22 in which the social and political attitudes of 
lottery winners were compared; lotteries are random processes, and there is, consequently, 
a very high degree of randomness (although not total) in the separation of winners and non-
winners. In other situations, the ‘as if random’ assumption may be more speculative. 
iii. In practical terms, it might be appropriate to consider implementing a data monitoring 
committee and to determine stopping rules, based on interim analyses, for any preventable 
harms.26 
iv. In a case–control study design, groups are defined in terms of their either having (cases) or 
not having (controls) the outcome of interest. These groups are then compared statistically 
in terms of their relative prior exposure to a potential causative factor. As the exposure 
predates the study, the researcher is not responsible for its occurring or for any associated 
harms. 
v. The literature on the doing/allowing distinction is vast and primarily focused on whether 
doing harm is somehow worse than allowing a harm to occur. Intuitions and moral theories 
will differ about what answer they give to this question.33 Our caution to researchers here 
does not require that there is strict equivalent moral value to be assigned to the outcomes 
of doing and allowing, but rather that there is at least sometimes moral responsibility for 
known potentially harmful outcomes. This less demanding requirement is generally seen to 
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impose a strong obligation to act to prevent harm, at least in research ethics. For example, 
where a researcher comes to believe that one treatment option is demonstrated to be 
preferable, equipoise is disturbed and action is required. Where a researcher does not act, 
an appeal to the fact that the harm was only allowed to happen will not excuse (at least 
some) responsibility for the outcome. 
vi. In instances where risk of harm is of very slight magnitude (e.g., constituting little more than 
inconvenience), consent might not even be a necessary condition. 
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